(Q44482347)

3 December 2017

title

Nonmyeloablative bone marrow transplantation: Infectious complications in 65 recipients of HLA-identical and mismatched transplants (English)

1 reference

3 December 2017

8

Nancy J Tarbell

1 reference

3 December 2017

Andrew Daly

1

1 reference

3 December 2017

Steven McAfee

2

1 reference

3 December 2017

Bimal Dey

3

1 reference

3 December 2017

Christine Colby

4

1 reference

3 December 2017

Leah Schulte

5

1 reference

3 December 2017

Beow Yeap

6

1 reference

3 December 2017

Robert Sackstein

7

1 reference

3 December 2017

David Sachs

9

1 reference

3 December 2017

Megan Sykes

10

1 reference

3 December 2017

Thomas R Spitzer

11

1 reference

3 December 2017

publication date

1 June 2003

1 reference

Biology of Blood and Marrow Transplantation

3 December 2017

published in

1 reference

3 December 2017

volume

9

1 reference

3 December 2017

issue

6

1 reference

3 December 2017

page(s)

373-382

1 reference

Prevention of infections in bone marrow transplant recipients

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

Engraftment syndrome following hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

CMV antigenemia following bone marrow transplantation: risk factors and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

Cytomegalovirus Infection and Specific Cell-Mediated Immunity after Marrow Transplant

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

Bacteremias and fungemias in oncologic patients with central venous catheters: changing spectrum of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

The Effect of Prophylactic Fluconazole on the Clinical Spectrum of Fungal Diseases in Bone Marrow Transplant Recipients with Special Attention to Hepatic Candidiasis: An Autopsy Study of 355 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

Invasive mold infections in allogeneic bone marrow transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

Invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900100-9

7 January 2021

10.1016/S1083-8791(03)00100-9

Identifiers

DOI

1 reference

3 December 2017

1 reference